chrX-137030462-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_054021.2(GPR101):āc.1213A>Gā(p.Ile405Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000993 in 1,209,040 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_054021.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR101 | NM_054021.2 | c.1213A>G | p.Ile405Val | missense_variant | 2/2 | ENST00000651716.2 | NP_473362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR101 | ENST00000651716.2 | c.1213A>G | p.Ile405Val | missense_variant | 2/2 | NM_054021.2 | ENSP00000498972.1 | |||
ENSG00000291054 | ENST00000693626.2 | n.394-30063T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000541 AC: 6AN: 110970Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33198
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183128Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67568
GnomAD4 exome AF: 0.00000546 AC: 6AN: 1098070Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 2AN XY: 363432
GnomAD4 genome AF: 0.0000541 AC: 6AN: 110970Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33198
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.1213A>G (p.I405V) alteration is located in exon 1 (coding exon 1) of the GPR101 gene. This alteration results from a A to G substitution at nucleotide position 1213, causing the isoleucine (I) at amino acid position 405 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at